Posts Tagged ‘pharmaceutical’

Johnson & Johnson has a strong track record of consistently outperforming Wall Street’s expectations and we are expecting that trend to continue again this quarter.

Based on our analysis, we are expecting TEVA to report better than expected results that exceed Wall Street’s consensus expectations.